Catalyst Pharmaceuticals Inc (NAS:CPRX)
$ 31.49 +0.0050 (+0.02%) Market Cap: 3.85 Bil Enterprise Value: 3.10 Bil PE Ratio: 18.10 PB Ratio: 3.80 GF Score: 70/100

Catalyst Pharmaceuticals Inc at Citi Global Healthcare Conference Transcript

Dec 02, 2025 / 06:00PM GMT
Release Date Price: $22.62 (-0.31%)
Samantha Semenkow
Citi Infrastructure Investments LLC - Analyst

Today, it's my pleasure to be hosting Catalyst Pharmaceuticals for a fireside chat at Citi's Global Healthcare Conference. I'm joined today by CEO, Rich Daly; CFO, Mike Kalb; and Chief Commercial Officer, Jeff Del Carmen. Thank you so much for being here today, Rich, Mike and Steve.

Questions & Answers

Samantha Semenkow
Citi Infrastructure Investments LLC - Analyst

To start, maybe, Rich, you could just like level set for us for those that might not be familiar that are listening in, can you just give us an overview of Catalyst and each of your product candidates?

Richard Daly
Catalyst Pharmaceuticals Inc - Chief Executive Officer, Director

Sam, thanks for the opportunity to be here. We really appreciate it. Happy to go over the products and be joined by my colleagues here and to talk about the scope and span of the business. So Catalyst -- the focus of Catalyst is orphan and rare diseases. We have 3 products.

We have FIRDAPSE,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot